Serum peroxiredoxin 4: a marker of oxidative stress associated with mortality in type 2 diabetes (ZODIAC-28).

Autor: Gerrits EG; Department of Internal Medicine, Maastricht University Medical Center, Maastricht, The Netherlands ; Diabetes Centre, Isala Clinics, Zwolle, The Netherlands., Alkhalaf A; Diabetes Centre, Isala Clinics, Zwolle, The Netherlands ; Department of Gastroenterology, Isala Clinics, Zwolle, The Netherlands., Landman GW; Diabetes Centre, Isala Clinics, Zwolle, The Netherlands., van Hateren KJ; Diabetes Centre, Isala Clinics, Zwolle, The Netherlands ; Langerhans Medical Research Group, Zwolle, The Netherlands., Groenier KH; Diabetes Centre, Isala Clinics, Zwolle, The Netherlands ; Department of General Practice, University Medical Center Groningen, Groningen, The Netherlands., Struck J; Thermo Fisher Scientific, BRAHMS Biomarkers, Research Department, Hennigsdorf, Germany., Schulte J; Thermo Fisher Scientific, BRAHMS Biomarkers, Research Department, Hennigsdorf, Germany., Gans RO; Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands., Bakker SJ; Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands., Kleefstra N; Diabetes Centre, Isala Clinics, Zwolle, The Netherlands ; Langerhans Medical Research Group, Zwolle, The Netherlands ; Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands., Bilo HJ; Diabetes Centre, Isala Clinics, Zwolle, The Netherlands ; Department of Internal Medicine, University Medical Center Groningen, Groningen, The Netherlands ; Department of Internal Medicine, Isala Clinics, Zwolle, The Netherlands.
Jazyk: angličtina
Zdroj: PloS one [PLoS One] 2014 Feb 25; Vol. 9 (2), pp. e89719. Date of Electronic Publication: 2014 Feb 25 (Print Publication: 2014).
DOI: 10.1371/journal.pone.0089719
Abstrakt: Background: Oxidative stress plays an underlying pathophysiologic role in the development of diabetes complications. The aim of this study was to investigate peroxiredoxin 4 (Prx4), a proposed novel biomarker of oxidative stress, and its association with and capability as a biomarker in predicting (cardiovascular) mortality in type 2 diabetes mellitus.
Methods: Prx4 was assessed in baseline serum samples of 1161 type 2 diabetes patients. Cox proportional hazard models were used to evaluate the relationship between Prx4 and (cardiovascular) mortality. Risk prediction capabilities of Prx4 for (cardiovascular) mortality were assessed with Harrell's C statistic, the integrated discrimination improvement and net reclassification improvement.
Results: Mean age was 67 and the median diabetes duration was 4.0 years. After a median follow-up period of 5.8 years, 327 patients died; 137 cardiovascular deaths. Prx4 was associated with (cardiovascular) mortality. The Cox proportional hazard models added the variables: Prx4 (model 1); age and gender (model 2), and BMI, creatinine, smoking, diabetes duration, systolic blood pressure, cholesterol-HDL ratio, history of macrovascular complications, and albuminuria (model 3). Hazard ratios (HR) (95% CI) for cardiovascular mortality were 1.93 (1.57 - 2.38), 1.75 (1.39 - 2.20), and 1.63 (1.28 - 2.09) for models 1, 2 and 3, respectively. HR for all-cause mortality were 1.73 (1.50 - 1.99), 1.50 (1.29 - 1.75), and 1.44 (1.23 - 1.67) for models 1, 2 and 3, respectively. Addition of Prx4 to the traditional risk factors slightly improved risk prediction of (cardiovascular) mortality.
Conclusions: Prx4 is independently associated with (cardiovascular) mortality in type 2 diabetes patients. After addition of Prx4 to the traditional risk factors, there was a slightly improvement in risk prediction of (cardiovascular) mortality in this patient group.
Databáze: MEDLINE
Externí odkaz: